サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：スマート吸入器の市場規模、シェア、動向分析レポート：タイプ別（乾燥粉末吸入器、定量吸入器）、適応症別（喘息、COPD）、流通チャネル別、最終用途別、地域別、セグメント予測、2022年～2030年
市場調査レポート
商品コード
1170894

スマート吸入器の市場規模、シェア、動向分析レポート：タイプ別（乾燥粉末吸入器、定量吸入器）、適応症別（喘息、COPD）、流通チャネル別、最終用途別、地域別、セグメント予測、2022年～2030年

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
スマート吸入器の市場規模、シェア、動向分析レポート：タイプ別（乾燥粉末吸入器、定量吸入器）、適応症別（喘息、COPD）、流通チャネル別、最終用途別、地域別、セグメント予測、2022年～2030年
出版日: 2022年11月07日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

スマート吸入器市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界のスマート吸入器市場規模は2030年までに533億米ドルに達し、2022年から2030年までCAGR19.3％で拡大すると予測されています。喘息、慢性閉塞性肺疾患（COPD）、嚢胞性線維症、肺疾患などの慢性呼吸器疾患（CRD）の有病率の上昇が、市場の成長に寄与しています。欧州呼吸器学会大会によると、COPDは2022年に全世界で4億8000万人以上が罹患すると予想されています。

COVID-19は、呼吸器や肺のケアのための最先端のデジタル機器やソリューションの普及が進んでいるため、スマート吸入器の需要を高めています。さらに、ポストパンデミック時代には、ヘルスケアプロバイダーが、状況にかかわらず、患者がより良い、より充実したケアを受けられるように、接続型医療機器に注目しているため、スマート吸入器の採用が進むと予想されます。

さらに、投薬の効率化や喘息・COPDの管理を目的に、製品にデジタル技術を取り入れる事業者も増えています。また、2022年4月には、市場の主要企業であるAptar Pharma社が、従来の定量吸入器をスマート吸入器に変換する斬新なデジタル慢性呼吸器eヘルスソリューション「HeroTracker Sense」を発表しています。さらに、Adheriumスマート吸入器の研究により、スマート吸入器のユーザーは、入院の減少、服薬アドヒアランスの改善、医師の診察の必要性の減少など、いくつかの有益な医療成果を経験したことも明らかになりました。

スマート吸入器市場レポートハイライト

タイプ別では、定量噴霧式吸入器（MDI）セグメントが2021年に60.0%超の最大シェアを占めています。MDIは、CRDの治療に使用される最も好ましい吸入器です。乾燥粉末吸入器（DPI）セグメントは、薬物送達に使用しやすい機構の利便性により、予測期間中に18.6%の最速成長率を記録すると予想されます。

適応症別では、COPDの有病率が高く、世界で2億人が罹患していることから、2021年にはCOPD分野が50.0%超の最大シェアを占めています。喘息分野は、特に幼児における喘息による入院件数の増加により、予測期間中に18.3%の最速成長率が見込まれています。

流通チャネル別では、2021年に病院薬局部門が40.0%超の最大シェアを占めました。高齢者層はCRDで入院治療を受けることが多く、病院内薬局での薬剤購入を検討しています。小売薬局セグメントは、市場への浸透を高めるために、既存の薬局の迅速な拡張と近代化により、予測期間中に19.2%の成長率が予測される

エンドユーザー別では、病院が製薬会社と患者の間の重要な流通チャネルであることから、2021年には病院セグメントが50.0%超の最大シェアを占めました。高齢患者の間での嗜好の高まり、ヘルスケアコストの上昇、自宅での治療がもたらす利便性などから、在宅医療環境セグメントは予測期間中に20.2%の最速成長を遂げると予想される

2021年には、北米が45.0%以上のシェアを占め、同地域におけるCRDの有病率の上昇により、市場を独占しました。米国では、2,500万人以上の人々が喘息に苦しんでいます。中国やインドなどの発展途上国におけるCOPDおよび喘息の発症率の上昇により、予測期間中にアジア太平洋地域が21.2%と最も速い速度で拡大すると予想される

目次

第1章 調査範囲と目的

  • 市場セグメンテーションと範囲
  • 地域範囲
  • 目的

第2章 調査手法

  • 調査手法
  • 情報調達
    • 購入したデータベース
    • Gvrの内部データベース
    • 二次情報
    • 1次調査
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析（モデル1）
    • 出来高価格分析（モデル2）
  • 二次情報一覧

第3章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
    • タイプ
    • 表示
    • 流通経路
    • 最終用途
    • 領域
  • 競合考察
  • スマート吸入器市場の見通し、2021年

第4章 市場変数、動向、範囲

  • 市場系列の見通し
    • 親市場の見通し
    • アンシラリー市場の見通し
  • スマート吸入器市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • スマート吸入器市場：事業環境分析ツール
    • ポーターのファイブフォース分析
      • 新規参入業者の脅威
      • 供給企業の交渉力
      • 買い手の交渉力
      • 競争企業間の敵対関係
      • 代替品の脅威
    • PESTEL分析
      • 政治と法律
      • 経済と社会
      • 技術的な
      • 環境
  • 浸透と成長の見通しのマッピング
  • 技術トレンド分析
  • 規制の枠組み
  • COVID-19がスマート吸入器市場に与える影響

第5章 スマート吸入器市場：タイプ分析

  • スマート吸入器タイプの市場シェア分析、2021年および2030年
  • スマート吸入器タイプ市場：セグメントダッシュボード
  • タイプセグメントの市場規模と予測、トレンド分析、2017年から2030年
    • 乾燥粉末吸入器
    • 定量吸入器

第6章 スマート吸入器市場：適応分析

  • スマート吸入器適応症市場シェア分析、2021年および2030年
  • スマート吸入器適応市場：セグメントダッシュボード
  • 適応症セグメントの2017年から2030年までの市場規模と予測、トレンド分析
    • 喘息
    • Copd
    • その他

第7章 スマート吸入器市場：流通チャネル分析

  • スマート吸入器の流通チャネル市場シェア分析、2021年および2030年
  • スマート吸入器流通チャネル市場：セグメントダッシュボード
  • 流通チャネルの市場規模と予測、トレンド分析、2017年から2030年
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第8章 スマート吸入器市場：エンドユース分析

  • スマート吸入器の最終用途市場シェア分析、2021年および2030年
  • スマート吸入器最終用途市場：セグメントダッシュボード
  • 最終用途セグメントの市場規模と予測、およびトレンド分析、2017年から2030年
    • 病院
    • ホームケアの設定
    • その他

第9章 スマート吸入器市場：地域分析

  • スマート吸入器の地域市場シェア分析、2021年および2030年
  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • シンガポール
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東およびアフリカ（MEA）
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第10章 競合分析

  • 主要な市場参入企業別最近の動向と影響分析
  • 企業プロファイル
    • H&T PRESSPART MANUFACTURING LTD.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • PERSONAL AIR QUALITY SYSTEMS PRIVATE LIMITED
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • COHERO HEALTH INC.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • COGNITA LABS
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • ADHERIUM LIMITED
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • AMIKO DIGITAL HEALTH LIMITED
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • TEVA PHARMACEUTICALS INDUSTRIES LTD.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • PROPELLER HEALTH
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • NOVARTIS AG
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • PNEUMA RESPIRATORY, INC.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • 3M HEALTH CARE LIMITED
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • FINDAIR SP Z O O
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • AIREHEALTH, INC.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 North America smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 3 North America smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 4 North America smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 5 North America smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 6 North America smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 7 U.S. smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 8 U.S. smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 9 U.S. smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 10 U.S. smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 11 Canada smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 12 Canada smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 13 Canada smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 14 Canada smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 15 Europe smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 16 Europe smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 17 Europe smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 18 Europe smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 19 Europe smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 20 U.K. smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 21 U.K. smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 22 U.K. smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 23 U.K. smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 24 Germany smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 25 Germany smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 26 Germany smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 27 Germany smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 28 France smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 29 France smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 30 France smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 31 France smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 32 Italy smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 33 Italy Smart Inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 34 Italy smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 35 Italy smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 36 Spain smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 37 Spain smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 38 Spain smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 39 Spain smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 40 Russia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 41Russia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 42 Russia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 43 Russia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 44 Asia Pacific smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 45 Asia Pacific smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 46 Asia Pacific smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 47 Asia Pacific smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 48 Asia Pacific smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 49 Japan smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 50 Japan smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 51 Japan smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 52 Japan smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 53 China smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 54 China smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 55 China smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 56 China smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 57 India smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 58 India smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 59 India smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 60 India smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 61 Australia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 Australia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 Australia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 Australia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)'
  • Table 61 South Korea smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 South Korea smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 South Korea smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 South Korea smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 61 Singapore smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 Singapore smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 Singapore smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 Singapore smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 65 Latin America smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 66 Latin America smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 67 Latin America smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 68 Latin America smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 69 Latin America smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 70 Brazil smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 71 Brazil smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 72 Brazil smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 73 Brazil smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 74 Mexico smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 75 Mexico smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 76 Mexico smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 77 Mexico smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 74 Argentina smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 75 Argentina smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 76 Argentina smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 77 Argentina smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 78 MEA smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 71 MEA smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 72 MEA smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 73 MEA smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 74 MEA smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 South Africa smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 South Africa smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 South Africa smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 South Africa smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 Saudi Arabia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 Saudi Arabia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 Saudi Arabia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 Saudi Arabia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 UAE smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 UAE smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 UAE smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 UAE smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Smart inhalers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Smart Inhalers market outlook, 2021 (USD Million)
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Smart inhalers type market share analysis, 2022 & 2030 (USD Million)
  • Fig. 15 Smart inhalers type market: Segment dashboard
  • Fig. 16 Metered dose inhalers (MDIs) market, 2017 - 2030 (USD Million)
  • Fig. 17 Dry powdered inhalers (DPIs) market, 2017 - 2030 (USD Million)
  • Fig. 18 Smart inhalers indication market share analysis, 2021 & 2030 (USD Million)
  • Fig. 19 Smart inhalers indication market: Segment dashboard
  • Fig. 20 Asthma market, 2017 - 2030 (USD Million)
  • Fig. 21 COPD market, 2017 - 2030 (USD Million)
  • Fig. 22 Others market, 2017 - 2030 (USD Million)
  • Fig. 23 Smart inhalers distribution channel market share analysis, 2021 & 2030 (USD Million)
  • Fig. 24 Smart inhalers distribution channel market: Segment dashboard
  • Fig. 25 Hospital pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 26 Retail pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 27 Online pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 28 Smart inhalers end-use market share analysis, 2021 & 2030 (USD Million)
  • Fig. 29 Smart inhalers end-use market: Segment dashboard
  • Fig. 30 Hospitals market segmentation market, 2017 - 2030 (USD Million)
  • Fig. 31 Homecare settings market segmentation market, 2017 - 2030 (USD Million)
  • Fig. 32 Smart inhalers regional market share analysis, 2021 & 2030 (USD Million)
  • Fig. 33 Regional market place: Key takeaways
  • Fig. 34 North America smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 35 U.S. smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 36 Canada smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 37 Europe smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 38 U.K. smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 39 Germany smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 40 France smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 41 Italy smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 42 Spain smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 42 Russia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 43 Asia Pacific smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 44 Japan smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 45 China smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 India smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 Australia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 South Korea smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 Singapore smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 47 Latin America smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 48 Brazil smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 49 Mexico smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 49 Argentina smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 50 MEA smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 South Africa smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 UAE smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 52 Strategy framework
目次
Product Code: GVR-4-68039-993-1

Smart Inhalers Market Growth & Trends:

The global smart inhalers market size is expected to reach USD 53.3 billion by 2030, based on a new report by Grand View Research, Inc., expanding at a CAGR of 19.3% from 2022 to 2030. The rising prevalence of chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and lung disorders is contributing to the growth of the market. According to the European Respiratory Society Congress, COPD is expected to affect over 480 million people in 2022 across the globe.

COVID-19 has increased the demand for smart inhalers due to the rising penetration of cutting-edge digital devices and solutions for respiratory and pulmonary care. Furthermore, in the post-pandemic era, it is expected that the adoption of smart inhalers will increase as healthcare providers are focusing on connected medical devices to ensure that patients receive better and more enhanced care, regardless of the circumstance.

Furthermore, a growing number of businesses are incorporating digital technologies into their products to improve the efficiency of medication and the management of asthma and COPD. In addition, in April 2022, Aptar Pharma, a key market player, introduced HeroTracker Sense, a novel digital chronic respiratory e-health solution that converts a traditional metered dose inhaler into a smart inhaler. Furthermore, a study of the Adherium Smart inhaler also revealed that smart inhaler users experienced several beneficial medical outcomes, including fewer hospitalizations, improved medication adherence, and a decreased need for doctor visits.

Smart Inhalers Market Report Highlights:

  • Based on type, the metered dose inhalers (MDIs) segment held the largest share of over 60.0% in 2021. MDIs are the most preferred inhalers used to treat CRDs. The dry powdered inhalers (DPIs) segment is expected to register the fastest growth rate of 18.6% over the forecast period owing to the convenience of its mechanism, which makes it easier to use for medicine delivery
  • Based on indication, the COPD segment held the largest share of over 50.0% in 2021 due to the high prevalence of COPD as it affects 200 million people globally. The asthma segment is anticipated to grow at the fastest rate of 18.3% over the forecast period owing to the rising number of hospitalizations for asthma, particularly in young children
  • Based on distribution channel, the hospital pharmacies segment held the largest share of over 40.0% in 2021. The elderly population frequently receives hospital care for CRDs, and they consider purchasing medication from hospital pharmacies. The retail pharmacies segment is anticipated to grow at a rate of 19.2% over the forecast period due to the quick expansion and modernization of the existing pharmacies to increase market penetration
  • Based on end-use, the hospitals segment accounted for the largest share of over 50.0% in 2021 as hospitals are a crucial distribution channel between pharmaceutical companies and patients. The home care settings segment is anticipated to grow at the fastest rate of 20.2% over the forecast period due to the growing preference among older patients, rising costs of healthcare, and the convenience offered by the treatments at home
  • In 2021, North America dominated the market with a share of over 45.0% owing to the rising prevalence of CRDs in the region. In the U.S., more than 25 million people suffer from asthma. Asia Pacific is expected to expand at the fastest rate of 21.2% during the forecast period owing to rising incidence rates of COPD and asthma in developing nations such as China and India

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation & Scope
  • 1.2 Regional Scope
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Objectives
    • 1.3.1 Objective - 1
    • 1.3.2 Objective - 2
    • 1.3.3 Objective - 3

Chapter 2 Methodology

  • 2.1 Research Methodology
  • 2.2 Information Procurement
    • 2.2.1 Purchased Database
    • 2.2.2 Gvr's Internal Database
    • 2.2.3 Secondary Sources
    • 2.2.4 Primary Research
  • 2.3 Information or Data Analysis
    • 2.3.1 Data Analysis Models
  • 2.4 Market Formulation & Validation
  • 2.5 Model Details
    • 2.5.1 Commodity Flow Analysis (Model 1)
    • 2.5.2 Volume Price Analysis (Model 2)
  • 2.6 List of Secondary Sources

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 type
    • 3.2.2 Indication
    • 3.2.3 distribution Channel
    • 3.2.4 end-Use
    • 3.2.5 Region
  • 3.3 Competitive Insights
  • 3.4 Smart Inhalers Market Outlook, 2021

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
    • 4.1.2 Ancillary Market Outlook
  • 4.2 Smart Inhalers Market Dynamics
    • 4.2.1 Market Driver Analysis
    • 4.2.2 Market Restraint Analysis
  • 4.3 Smart Inhalers Market: Business Environment Analysis Tools
    • 4.3.1 Porter's Five Forces Analysis
      • 4.3.1.1 Threat Of New Entrants
      • 4.3.1.2 Bargaining Power Of Suppliers
      • 4.3.1.3 Bargaining Power Of Buyers
      • 4.3.1.4 Competitive Rivalry
      • 4.3.1.5 Threat Of Substitutes
    • 4.3.2 Pestel Analysis
      • 4.3.2.1 Political & Legal
      • 4.3.2.2 Economic & social
      • 4.3.2.3 Technological
      • 4.3.2.4 Environmental
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Technology Trend Analysis
  • 4.6 Regulatory Framework
  • 4.7 Impact of COVID-19 on Smart Inhalers Market

Chapter 5 Smart Inhalers Market: Type Analysis

  • 5.1 Smart Inhalers Type Market Share Analysis, 2021 & 2030
  • 5.2 Smart Inhalers Type Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment
    • 5.3.1 Dry Powdered Inhalers
      • 5.3.1.1 Dry Powdered Inhalers (Dpis) Market, 2017 - 2030 (USD Million)
    • 5.3.2 Metered Dose Inhalers
      • 5.3.2.1 Metered dose inhalers (MDIs) market, 2017 - 2030 (USD Million)

Chapter 6 Smart Inhalers Market: Indication Analysis

  • 6.1 Smart Inhalers Indication Market Share Analysis, 2021 & 2030
  • 6.2 Smart Inhalers Indication Market: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Indication Segment
    • 6.3.1 Asthma3
      • 6.3.1.1 Asthma Market, 2017 - 20302017 - 20302017 - 2030 (USD Million)
    • 6.3.2 Copd
      • 6.3.2.1 Copd Market, 2017 - 2030 (USD Million)
    • 6.3.3 Others
      • 6.3.3.1 Others market, 2017 - 2030 (USD Million)

Chapter 7 Smart Inhalers Market: Distribution Channel Analysis

  • 7.1 Smart Inhalers Distribution Channel Market Share Analysis, 2021 & 2030
  • 7.2 Smart Inhalers Distribution Channel Market: Segment Dashboard
  • 7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Distribution Channel
    • 7.3.1 Hospitals Pharmacies
      • 7.3.1.1 Hospitals Pharmacies Market, 2017 - 2030 (USD Million)
    • 7.3.2 Retail Pharmacies
      • 7.3.2.1 Retail Pharmacies Market, 2017 - 2030 (USD Million)
    • 7.3.3 Online Pharmacies
      • 7.3.3.1 Online pharmacies market, 2017 - 2030 (USD Million)

Chapter 8 Smart Inhalers Market: End-Use Analysis

  • 8.1 Smart Inhalers end-use Market Share Analysis, 2021 & 2030
  • 8.2 Smart Inhalers End-Use Market: Segment Dashboard
  • 8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment
    • 8.3.1 Hospitals
      • 8.3.1.1 Hospitals Market, 2017 - 2030 (USD Million)
    • 8.3.2 Homcare Settings
      • 8.3.2.1 Homecare Settings Market, 2017 - 2030 (USD Million)
    • 8.3.3 Others
      • 8.3.3.1 Others market, 2017 - 2030 (USD Million)

Chapter 9 Smart Inhalers Market: Regional Analysis

  • 9.1 Smart Inhalers Regional Market Share Analysis, 2021 & 2030
  • 9.2 Regional Market Snapshot
  • 9.3 North America
    • 9.3.1 North America Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.3.2 U.S.
      • 9.3.2.1 U.S. Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.3.3 Canada
      • 9.3.3.1 Canada Smart Inhalers Market, 2017 - 2030 (USD Million)
  • 9.4 Europe
    • 9.4.1 Europe Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.2 U.K.
      • 9.4.2.1 U.K. Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.3 Germany
      • 9.4.3.1 Germany Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.4 France
      • 9.4.4.1 France smart inhalers market, 2017 - 2030 (USD Million)
    • 9.4.5 Italy
      • 9.4.5.1 Italy Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.6 Spain
      • 9.4.6.1 Spain Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.7 Russia
      • 9.4.7.1 Russia smart inhalers market, 2017 - 2030 (USD Million)
  • 9.5 Asia Pacific
    • 9.5.1 Asia Pacific Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.2 Japan
      • 9.5.2.1 Japan Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.3 China
      • 9.5.3.1 China Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.4 India
      • 9.5.4.1 India Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.5 Australia
      • 9.5.5.1 Australia Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.6 South Korea
      • 9.5.6.1 South Korea Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.7 Singapore
      • 9.5.7.1 Singapore Smart inhalers market, 2017 - 2030 (USD Million)
  • 9.6 Latin America
    • 9.6.1 Latin America Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.2 Brazil
      • 9.6.2.1 Brazil Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.3 Mexico
      • 9.6.3.1 Mexico Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.4 Argentina
      • 9.6.4.1 Argentina Smart Inhalers market, 2017 - 2030 (USD Million)
  • 9.7 Middle East and Africa (MEA)
    • 9.7.1 MEA Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.7.2 South Africa
      • 9.7.2.1 South Africa Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.7.3 Saudi Arbia
      • 9.7.3.1 Saudi Arbia smart inhalers market, 2017 - 2030 (USD Million)
    • 9.7.4 UAE
      • 9.7.4.1 UAE smart inhalers market, 2017 - 2030 (USD Million)

Chapter 10 Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2 Company Profiles
    • 10.2.1 H&T PRESSPART MANUFACTURING LTD.
      • 10.2.1.1 Company overview
      • 10.2.1.2 Financial performance
      • 10.2.1.3 Product benchmarking
      • 10.2.1.4 Strategic initiatives
    • 10.2.2 PERSONAL AIR QUALITY SYSTEMS PRIVATE LIMITED
      • 10.2.2.1 Company overview
      • 10.2.2.2 Financial performance
      • 10.2.2.3 Product benchmarking
      • 10.2.2.4 Strategic initiatives
    • 10.2.3 COHERO HEALTH INC.
      • 10.2.3.1 Company overview
      • 10.2.3.2 Financial performance
      • 10.2.3.3 Product benchmarking
      • 10.2.3.4 Strategic initiatives
    • 10.2.4 COGNITA LABS
      • 10.2.2.1 Company overview
      • 10.2.2.2 Financial performance
      • 10.2.2.3 Product benchmarking
      • 10.2.2.4 Strategic initiatives
    • 10.2.4 ADHERIUM LIMITED
      • 10.2.4.1 Company overview
      • 10.2.4.2 Financial performance
      • 10.2.4.3 Product benchmarking
      • 10.2.4.4 Strategic initiatives
    • 10.2.5 AMIKO DIGITAL HEALTH LIMITED
      • 10.2.5.1 Company overview
      • 10.2.5.2 Financial performance
      • 10.2.5.3 Product benchmarking
      • 10.2.5.4 Strategic initiatives
    • 10.2.6 TEVA PHARMACEUTICALS INDUSTRIES LTD.
      • 10.2.6.1 Company overview
      • 10.2.6.2 Financial performance
      • 10.2.6.3 Product benchmarking
      • 10.2.6.4 Strategic initiatives
    • 10.2.7 PROPELLER HEALTH
      • 10.2.7.1 Company overview
      • 10.2.7.2 Financial performance
      • 10.2.7.3 Product benchmarking
      • 10.2.7.4 Strategic initiatives
    • 10.2.8 NOVARTIS AG
      • 10.2.8.1 Company overview
      • 10.2.8.2 Financial performance
      • 10.2.8.3 Product benchmarking
      • 10.2.8.4 Strategic initiatives
    • 10.2.9 PNEUMA RESPIRATORY, INC.
      • 10.2.9.1 Company overview
      • 10.2.9.2 Financial performance
      • 10.2.9.3 Product benchmarking
      • 10.2.9.4 Strategic initiatives
    • 10.2.10 3M HEALTH CARE LIMITED
      • 10.2.10.1 Company overview
      • 10.2.10.2 Financial performance
      • 10.2.10.3 Product benchmarking
      • 10.2.10.4 Strategic initiatives
    • 10.2.11 FINDAIR SP. Z O.O.
      • 10.2.11.1 Company overview
      • 10.2.11.2 Financial performance
      • 10.2.11.3 Product benchmarking
      • 10.2.11.4 Strategic initiatives
    • 10.2.12 AIREHEALTH, INC.
      • 10.2.12.1 Company overview
      • 10.2.12.2 Financial performance
      • 10.2.12.3 Product benchmarking
      • 10.2.12.4 Strategic initiatives